|
JULY'S BEST FEATURED EDITORIAL |
|
|
Stitching The Future: Where Enzymatic Ligation Of siRNA Stands Today | By Advancing RNA | Is enzymatic ligation a futuristic dream or a current commercial reality? In this segment, industry experts Claire MacCleod and Jill Caswell explore how the sector has moved past the proof-of-concept stage into early commercialization and what this looks like/means for early adopters today. |
|
|
Targeting The Uncharted Heart: Why Next Era siRNA Belongs In Cardiology | By Anna Rose Welch, editorial & community director, Advancing RNA | During our conversation, Gallagher walked me through what’s keeping her up at night as she leads the company and its first siRNA candidate toward an IND, elaborating on the role RNA can play in cardiomyopathies and identifying unique challenges of developing RNA medicines. |
|
|
RNA Platforms: What Transfers And What Breaks | By Jyotsna Jajula, research assistant, Wayne State University | A practical framework for distinguishing reusable RNA platform knowledge from biology-specific unknowns as therapeutics expand into new tissues and indications. |
|
|
JULY'S BEST INDUSTRY INSIGHTS |
|
|
|
|
|
|
|
|
|
.png){kind=logo}